Current strategies for the targeted treatment of high-grade serous epithelial ovarian cancer and relevance of BRCA mutational status
Abstract Epithelial ovarian cancer is the most lethal gynecologic malignancy. In most women, it is diagnosed at an advanced stage, which largely explains the poor prognosis of this malignancy. Germline mutations of the genes BRCA1 and BRCA2, which encode proteins essential for the repair of double-s...
Saved in:
Main Authors: | Angiolo Gadducci (Author), Valentina Guarneri (Author), Fedro Alessandro Peccatori (Author), Graziana Ronzino (Author), Giuseppa Scandurra (Author), Claudio Zamagni (Author), Paolo Zola (Author), Vanda Salutari (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2019-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Low grade serous carcinoma of the peritoneum in a BRCA1 carrier previously diagnosed with a "low-grade serous tubal intra-epithelial carcinoma" (STIC) on risk reducing surgery
by: Wen Yee Chay, et al.
Published: (2015) -
BRCA mutation in high grade epithelial ovarian cancers
by: Tarinee Manchana, et al.
Published: (2019) -
Perivascular epithelioid cell tumors (PEComa) of the female genital tract: A challenging question for gynaecologic oncologist and pathologist
by: Angiolo Gadducci, et al.
Published: (2020) -
BRCA immunohistochemistry for screening of BRCA mutation in epithelial ovarian cancer patients
by: Tarinee Manchana, et al.
Published: (2020) -
COVID-19: a plea to protect the older population
by: Daniele Carrieri, et al.
Published: (2020)